BrainsWay’s patented breakthrough treatment based on Deep TMS™ begins a new era in brain stimulation and research. This non-invasive and effective treatment activates deep brain structures by using directed electromagnetic fields that generate excitation or inhibition of neurons deep inside the brain.
BrainsWay’s Deep TMS flagship technology is based on the H-Coil, which features a novel patented structure designed to maximize electrical stimulation of deep brain regions and includes the following unique features:
BrainsWay’s treatment was cleared by the FDA in 2013 for patients who tried any number of antidepressants with no improvement in the current depressive episode. The FDA indication is based on a unique 16-week double-blind, placebo-controlled, multi-center study which enrolled over 200 subjects, and reported a marked decline in HDRS-21 scores, as well as significant remission (32.6%) and response (38.4%) rates at the primary endpoint of the study after four weeks of acute treatment. In the study, treatment with BrainsWay’s H-1 coil helmet was proven to be safe, and the treatment was well tolerated by the majority of the study subjects. The H1 Coil is also in clinical trials at various stages for the treatment of Bipolar Disorder, Post-Traumatic Stress Disorder and Schizophrenia.
In 2018, BrainsWay’s Deep TMS technology was cleared by the FDA (De Novo) for the treatment of Obsessive-Compulsive Disorder. In 11 medical centers worldwide, patients who had not responded to SSRIs and/or psychotherapy and received treatment for six consecutive weeks experienced a significant reduction in their OCD symptoms. BrainsWay’s H7 Coil, specifically designed to treat the anterior cingulate cortex, is the only TMS technology platform cleared by the FDA for this purpose.
The electric field induced by the coils stimulate a larger volume of gray matter in the prefrontal cortex (PFC) than do figure-8 coils.
Provide Patients More Options
BrainsWay Deep TMS is a powerful treatment method to add to your practice’s toolbox.
Figure-8 coils are more prone to targeting errors. The deeper and broader electric field induced by the H1-coil is much more likely to stimulate relevant prefrontal depression targets consistently.